Skip to main content

Table 2 Frequency of G6PD phenotype by centre and country

From: Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials

Country

Centre

N*

Deficient

Intermediate

Normal

BF

Bobo-Dioulasso

0

0

0

0

 

Ouagadougou

343

29 (8.5)

37 (10.8)

277 (80.8)

 

Total

343

29 (8.5)

37 (10.8)

277 (80.8)

Ghana

Kintampo

118

8 (6.8)

15 (12.7)

95 (80.5)

 

Kumasi

20

1 (5.0)

0

19 (95.0)

 

Total

138

9 (6.5)

15 (10.9)

114 (82.6)

Kenya

Eldoret

90

15 (16.7)

4 (4.4)1

71 (78.9)

 

Kilifi

67

7 (10.4)

7 (10.4)

53 (79.1)

 

Pingilikani

62

4 (6.5)

3 (4.8)

55 (88.7)

 

Total

219

26 (11.9)

14 (6.4)

179 (81.7)

Mali

Doneguebougou

205

17 (8.3)

20 (9.8)

168 (82.0)

 

Banambani

89

10 (11.2)

11 (12.4)

68 (76.4)

 

Total

294

27 (9.2)

31 (10.5)

236 (80.3)

Nigeria

Calabar

21

5 (23.8)

2 (9.5)

14 (66.7)

 

Enugu

71

6 (8.5)

10 (14.1)

55 (77.5)

 

Ibadan

0

0

0

0

 

Ile Ife

72

7 (9.7)

4 (5.6)

61 (84.7)

 

Jos

0

0

0

0

 

Total

164

18 (11.0)

16 (9.8)

130 (79.3)

Tanzania

Bagamoyo

10

2 (20.0)

0

8 (80.0)

 

Kiwangwa

151

23 (15.2)

14 (9.3)

114 (75.5)

 

Total

161

25 (15.5)

14 (8.7)

122 (75.8)

Total

 

1319

134 (10.2)

127 (9.6)

1058 (80.2)

  1. Frequencies are shown as n (%)
  2. *N is the number of patients with genotype and phenotype data.